Showing articles whose micro-themes are very close to:
#NCPE HTA
- No closely related articles found yet.
- NCPE Recommends Belzutifan (Welireg) Not Reimbursed for VHL Disease on Cost-Effectiveness Grounds (ncpe.ie) | 39d ago
- Seanad Éireann Debate on NCPE Cost-Benefit Analysis (oireachtas.ie) | 124d ago
- Rapid Review of Rozanolixizumab (Rystiggo) for gMG Completed by NCPE (ncpe.ie) | 11d ago
Showing page 1 of 1
(3 total results)
← Prev
Next →